HIV DNA vaccine topical - Genetic Immunity

Alternative Names: DermaVir Patch; LC002

Latest Information Update: 02 Oct 2021

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Genetic Immunity LLC
Developer Genetic Immunity; Karolinska Institute; National Institute of Allergy and Infectious Diseases; Virostatics
Class AIDS vaccines; DNA vaccines
Mechanism of Action Immunostimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

18 Dec 2018 HIV DNA vaccine topical is licensed for marketing to Pharmadis in Russia and Commonwealth of Independent States
18 Dec 2018 Genetic Immunity plans to submit an IND application with the USFDA for HIV-1 infections
18 Dec 2018 Genetic Immunity plans a clinical trial for HIV-1 infections in Russia in first half of 2019

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com